Post hoc analysis of reactogenicity trends between dose 1 and dose 2 of the adjuvanted recombinant zoster vaccine in two parallel randomized trials

Post hoc analysis of reactogenicity trends between dose 1 and dose 2 of the adjuvanted recombinant zoster vaccine in two parallel randomized trials

In two large clinical trials (ZOE-50 [NCT01165177] and ZOE-70 [NCT01165229]), two doses of the adjuvanted recombinant zoster vaccine (RZV) demonstrated >90% efficacy against herpes zoster in adults ≥50 years of age. Solicited adverse events (AEs) were collected for 7 days post-each dose in a stud...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Romulo Colindres, Valentine Wascotte, Alain Brecx, Christopher Clarke, Caroline Hervé, Joon Hyung Kim, Myron J. Levin, Lidia Oostvogels, Toufik Zahaf, Anne Schuind, Anthony L. Cunningham
Formáid:	Alt
Teanga:	English
Foilsithe / Cruthaithe:	Taylor & Francis Group 2020-11-01
Sraith:	Human Vaccines & Immunotherapeutics
Ábhair:	recombinant herpes zoster vaccine reactogenicity doses healthcare professionals adverse events
Rochtain ar líne:	http://dx.doi.org/10.1080/21645515.2020.1741312

Míreanna comhchosúla

Efficacy, reactogenicity, and safety of the adjuvanted recombinant zoster vaccine for the prevention of herpes zoster in Chinese adults ≥ 50 years: A randomized, placebo-controlled trial
de réir: Diana Alexandra Echeverria Proano, et al.
Foilsithe / Cruthaithe: (2024-12-01)

Evaluation of two frailty indices, with practical application in a vaccine clinical trial
de réir: Desmond Curran, et al.
Foilsithe / Cruthaithe: (2019-12-01)

Vaccine profile of herpes zoster (HZ/su) subunit vaccine
de réir: Anthony L. Cunningham, et al.
Foilsithe / Cruthaithe: (2017-07-01)

Safety of live attenuated varicella-zoster vaccine in patients with underlying illnesses compared with healthy adults: a prospective cohort study
de réir: Satoko Ohfuji, et al.
Foilsithe / Cruthaithe: (2019-01-01)

Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention
de réir: Nicolas Lecrenier, et al.
Foilsithe / Cruthaithe: (2018-07-01)

Studies with herpes zoster vaccines in immune compromised patients
de réir: Myron J. Levin, et al.
Foilsithe / Cruthaithe: (2017-12-01)

Herpes Zoster Ophthalmicus: Presentation, Complications, Treatment, and Prevention
de réir: John Litt, et al.
Foilsithe / Cruthaithe: (2024-06-01)

HERPES ZOSTER
de réir: Nowshad Khan
Foilsithe / Cruthaithe: (2014-09-01)

Herpes zoster ophthalmicus with ocular involvement in overtreated hyperthyroidism
de réir: Surbhi Khurana, et al.
Foilsithe / Cruthaithe: (2020-01-01)

Assessment of the potential public health impact of Herpes Zoster vaccination in Germany
de réir: Desmond Curran, et al.
Foilsithe / Cruthaithe: (2017-10-01)

Sacral (S1) herpes zoster
de réir: Chiriac A, et al.
Foilsithe / Cruthaithe: (2019-05-01)

Safety and immunogenicity of a Herpes Zoster subunit vaccine in Japanese population aged ≥50 years when administered subcutaneously vs. intramuscularly
de réir: Peter Vink, et al.
Foilsithe / Cruthaithe: (2017-03-01)

Immune responses to zoster vaccines
de réir: Myron J Levin, et al.
Foilsithe / Cruthaithe: (2019-04-01)

Reactivation of Herpes Zoster Keratitis Following Shingrix Vaccine
de réir: Tracy J. Lu, et al.
Foilsithe / Cruthaithe: (2022-02-01)

The Study of Herpes Zoster in Patients who Referred to the Dermatology Ward of Sina Hospital of Hamadan between 1994-98
de réir: Abbas Zamanian, et al.
Foilsithe / Cruthaithe: (2002-03-01)

Detection of varicella-zoster virus in saliva and plasma of patients with typical and atypical herpes zoster
de réir: Yinling Li, et al.
Foilsithe / Cruthaithe: (2024-11-01)

The review gives data on the clinical manifestations, complications, and epidemiological characteristics of herpes zoster.
de réir: N M Afonina, et al.
Foilsithe / Cruthaithe: (2013-11-01)

Herpes zoster (Shingles)
de réir: M. H. Motswaledi
Foilsithe / Cruthaithe: (2018-08-01)

Herpes Zoster and Immunogenicity and Safety of Zoster Vaccines in Transplant Patients: A Narrative Review of the Literature
de réir: Lei Wang, et al.
Foilsithe / Cruthaithe: (2018-07-01)

Soropositividade para HIV em doentes de herpes zoster Seropositivity for HIV among zoster patients
de réir: Mônica R. A. Vasconcellos, et al.
Foilsithe / Cruthaithe: (1990-10-01)

Herpes zoster ophthalmicus following recombinant zoster vaccine: A case report and brief literature review
de réir: Joshua M. Garcia, et al.
Foilsithe / Cruthaithe: (2024-01-01)

Herpes zoster admissions: The majority of patients are not immunised
de réir: Mina Raahimi, et al.
Foilsithe / Cruthaithe: (2025-03-01)

Disseminated herpes zoster with cauda equina symptoms
de réir: Corey J. Steinberg, et al.
Foilsithe / Cruthaithe: (2020-01-01)

Herpes zoster laryngitis
de réir: Santosh Kumar Swain, et al.
Foilsithe / Cruthaithe: (2020-01-01)

Persistence of immune response to an adjuvanted varicella-zoster virus subunit vaccine for up to year nine in older adults
de réir: Tino F. Schwarz, et al.
Foilsithe / Cruthaithe: (2018-06-01)

Herpes zoster ophthalmicus-induced oculomotor nerve palsy
de réir: Jennifer S. Harthan, et al.
Foilsithe / Cruthaithe: (2013-01-01)

The adjuvanted recombinant zoster vaccine is efficacious and safe in Asian adults ≥ 50 years of age: a sub-cohort analysis of the ZOE-50 and ZOE-70 randomized trials
de réir: Joon Hyung Kim, et al.
Foilsithe / Cruthaithe: (2021-07-01)

Postherpetic pseudohernia: A rare complication of herpes zoster
de réir: Fabian Rodriguez‐Bolanos, et al.
Foilsithe / Cruthaithe: (2022-06-01)

Early impact of the Australian national shingles vaccination program with the herpes zoster live attenuated vaccine
de réir: John Litt, et al.
Foilsithe / Cruthaithe: (2020-12-01)

A prospective study of herpes zoster in children
de réir: Bhumesh Kumar Katakam, et al.
Foilsithe / Cruthaithe: (2016-01-01)

THE IMPORTANT OF NEUROPHYSIOLOGY EXAMINATION IN DIAGNOSING SEGMENTAL ZOSTER PARESIS: CASE REPORT
de réir: Eric Hartono Tedyanto, et al.
Foilsithe / Cruthaithe: (2023-07-01)

S2k-Leitlinie zur Diagnostik und Therapie des Zoster und der Postzosterneuralgie
de réir: Gross, Gerd E., et al.
Foilsithe / Cruthaithe: (2020-03-01)

Herpes zoster infection in early adolescence: two case reports and review of the treatment approach
de réir: Muhammet Mesut Nezir Engin, et al.
Foilsithe / Cruthaithe: (2020-09-01)

Herpes zoster-clinical material analysis in the ten-year period
de réir: E. Kasumagić, et al.
Foilsithe / Cruthaithe: (2005-08-01)

Bullous herpes zoster masquerading as a bullous pemphigoid flare: A case report
de réir: Ahmed Shehadah, et al.
Foilsithe / Cruthaithe: (2023-01-01)

Clinical Manifestations of Herpes Zoster Associated with Complications in Children
de réir: Dong Ha Kang, et al.
Foilsithe / Cruthaithe: (2021-09-01)

Herpes zoster ophthalmicus in an healthy infant with intrauterine infection
de réir: R Megha, et al.
Foilsithe / Cruthaithe: (2022-01-01)

Herpes zoster of trigeminal nerve after dental extraction
de réir: Nagappa Guttiganur, et al.
Foilsithe / Cruthaithe: (2013-01-01)

A clinico-epidemiological study of childhood herpes zoster
de réir: Barnali Mitra, et al.
Foilsithe / Cruthaithe: (2018-01-01)

Vacina contra herpes-zóster
de réir: Jacyr Pasternak